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Received 22 January 2010; received in revised form 7 July 2010; accepted 19 August 2010Abstract The future application of human embryonic stem cells (hESC) for therapeutic approaches requires the development
of xeno-free culture conditions to prevent the potential transmission of animal pathogens or xenobiotic substances to hESC. An
important component of the majority of hESC culture systems developed is the requirement for fibroblasts to serve as feeders.
For this purpose, several studies have used human foreskin fibroblasts established under xeno-free conditions. In this study we
report xeno-free establishment and maintenance of human embryonic fibroblasts (XHEF) and demonstrate their ability to
support long-term self-renewal of hESC under xeno-free culture conditions, using a commercially available complete medium.
Importantly, our culture conditions allow enzymatic passaging of hESC. In contrast, hESC cultured on human foreskin fibroblasts
(XHFF) under the same conditions were poorly maintained and rapidly subject to differentiation. Our study clearly shows that
the source of human fibroblasts is essential for long-term xeno-free hESC maintenance.
© 2010 Elsevier B.V. All rights reserved.Introduction them a promising tool for tissue replacement or repair, forSince their advent human embryonic stem cells (hESC)
(Thomson et al., 1998) have become the focus of
considerable interest in a broad area of life sciences
including regenerative medicine. Their ability to differen-
tiate into a spectrum of cell types of the human body makesAbbreviations: hESC, human embryonic stem cell; iPS, induced
pluripotent stem cell; MEF, mouse embryonic fibroblast; SR, serum
replacement; XHEF, xeno-free human embryonic fibroblast; XHFF,
xeno-free human foreskin fibroblast; ROCK, rho-associated kinase.
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doi:10.1016/j.scr.2010.08.002pharmaceutical approaches, and for research to understand
human organogenesis and development. Recently, the first
clinical trial using hESC derivates was cleared in the United
States, and more will probably follow in the near future
(Alper, 2009; Trounson, 2009). The generation of induced
pluripotent stem cells (iPS) has added a new dimension to
this field, promising the production of patient-specific
pluripotent stem cell lines for future cell-based therapies
(Takahashi et al., 2007; Takahashi and Yamanaka, 2006; Yu
et al., 2007). While iPS cells represent a new type of stem
cell, knowledge and methodologies developed to culture,
maintain, and differentiate hESC can be applied to iPS cells
and be of tremendous value in facilitating their potential
future scientific and therapeutic value (Robbins et al.,
2010)..
Figure 1 Morphology of xeno-free-derived human embryonic
and foreskin fibroblasts at low densities (A, C, E) and confluence
(B, D, E). Both xeno-free-derived human embryonic fibroblasts,
XHEFa (A, B) and XHEFb (C, D), show normal fibroblast
morphology, similar in appearance to foreskin fibroblast XHFFA
(E, F). Scale bars, 100 μm.
71Human embryonic fibroblastsThe culture conditions that are used for derivation and
growth of hESC lines were adapted from work with mouse ES
cells and contain several products of animal origin: mouse
embryonic fibroblasts (MEF) serving as feeders, serum
products from bovine, and gelatin and trypsin from swine.
Like all animal products used in human medicine, they are a
potential source for the transmission of nonhuman pathogens
(i.e., viruses) to the hESC and with these to humans (Amit et
al., 2003). In addition, animal pathogens can affect the hESC
themselves and alter their therapeutic capacities by leading
to an immune response in recipients (Martin et al., 2005). To
avoid the potential transfer of pathogens to hESC via culture
components, xeno-free culture conditions, which are free of
any animal product and contain only synthetic and recom-
binant products or those of human origin, must be generated
(Unger et al., 2008).
An important step in this process was the ability to culture
hESC under serum-free conditions using KnockOut serum
replacement (SR; Invitrogen). Media compositions using SR
instead of FBS also made prolonged propagation of undiffer-
entiated hESC possible, and provided more standardized
culture conditions (Amit et al., 2000; Koivisto et al., 2004).
Serum replacement in combination with mouse or human
fibroblast feeders or Matrigel as a substrate has became the
standard culture condition for hESC. However, SR is not
completely xeno-free as it contains animal proteins such as
BSA. Several studies have tested different xeno-free culture
media in combination with human fibroblast feeders to
culture hESC. Rajala et al. (Rajala et al., 2007) compared
nine different xeno-free media in combination with human
foreskin fibroblasts and found that none of them were able to
maintain the undifferentiated growth of hESC under xeno-
free culture conditions.
Meng et al. (2008) reported hESC culture using HEScGRO
xeno-free complete culture medium from Millipore and a
feeder layer from human foreskin fibroblasts. However, they
maintained the hESC bymechanical passaging of the colonies.
For rapid expansion of hESC cultures, transfection, and clonal
selection, enzymatic passaging giving a suspension of single
cells is essential. Enzymatic passaging of hESC using foreskin
fibroblast-supported cultures has been described before
(Ellerstrom et al., 2007), but this system was not xeno-free.
In this study, we derived xeno-free human embryonic
fibroblasts (XHEF) and used these as feeders for the hESC lines
CA1 and CA2. We used the HEScGRO xeno-free culture
medium, together with the ROCK inhibitor Y-27632 for
passaging, and could propagate the hESC lines enzymatically.
These fibroblasts are able to support the undifferentiated
growth of hESC lines in completely xeno-free long-term
cultures while maintaining their true pluripotent state,
karyotype, and differentiation capacities.
Results
Derivation and culture of xeno-free human
embryonic fibroblasts
In this study we derived xeno-free human embryonic
fibroblasts using two sources (named XHEFa and XHEFb)
from the connective tissues of fetuses at the end of the first
trimester of pregnancy. To maintain xeno-free conditions,the tissues were dissociated with TrypLE Select (a xeno-
component-free enzyme), and cells cultured in medium with
15% human serum and 10 ng/ml bFGF. The fibroblasts could
be cultured on standard cell culture dishes (Figs. 1A–D)
without coating; gelatin coating did not influence growth or
morphology of the fibroblasts. Tissue from each embryo was
sufficient to grow 3 confluent 10-cm dishes of XHEF resulting
in 15 stock vials at P0. Each of these vials can be expanded to
theoretically 54=625 stock vials at P4, which obviates
frequent preparation of fibroblasts. The cells from the two
embryo sources were cultured over 25 passages without
showing senescence, when routinely split 1:5 every 3 days.
Viability and proliferation properties remained after cryo-
preservation in 90% human serum with 10% DMSO, and both
fibroblast preparations tested negative for nine different
human pathogens as well as mycoplasms. PCR genotyping for
the amelogenin locus indicated that they were genetically
female (Fig. S1).
Feeder properties of embryonic fibroblasts for
xeno-free hESC cultures
Human foreskin fibroblasts (Figs. 1E, F) have been success-
fully used as feeders for the hESC line CA1 under xeno-free
culture conditions using HEScGRO complete culture medium
and mechanical passaging of cultures (Meng et al., 2008).
When we initially used these foreskin fibroblasts as feeders
for CA1 and CA2 in a xeno–free culture system using
enzymatic passaging with TrypLE Select, we experienced
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as well as low proliferation and the cultures were discon-
tinued within a few passages. The use of the rho-associated
kinas inhibitor (ROCK) Y-27632, which increases dissociation-
associated cell survival in hESC cultures (Watanabe et al.,
2007), led to better results concerning cell survival and
proliferation, but cultures still showed significant differen-
tiation (data not shown).
To investigate whether the xeno-free culture of CA1 and
CA2 using single cell passaging is dependent on the source of
the fibroblasts or other culture-related factors, we designed
an assay in which both hESC lines were compared in parallel
under standardized conditions. Thus, 3×105 mitomycin C-
arrested feeders were plated at the same density and
passage number (P5), onto 12-well culture dishes coated
with human recombinant gelatin, to eliminate any influence
by fibroblast passage number on the experiment. Using the
same batches of media and other culture components, low
passage hESC lines CA1 (P6) and CA2 (P9) that had previously
been cultured on MEF feeders in SR medium was transferred
onto human fibroblast feeders. The initial passage (named
P1) was plated in SR medium to reduce stress on the hESC;
24 h later the medium was changed to HEScGRO. The ROCK
inhibitor Y-27632 was used for passaging hESC and removed
from the medium 24 h after transfer. Over a period of
10 weeks (equal to 10 passages) 2×105 hESC were plated
every 7 days and monitored for morphology and growth.
Total cell numbers were counted at the day of passaging.
As summarized in Fig. 2, CA1 and CA2 could be
continuously maintained on both XHEFa and XHEFb for 38
passages. hESC grown on XHEF show a thinner colony
appearance with less defined edges compared to cultures
on MEF/SR. This change in morphology is, however, largely
dependent on the density of the feeders. Mitotically
inactivated embryonic fibroblasts proved to be more
sensitive to the HEScGRO medium compared to foreskinFigure 2 Schematic description and summary of hESC cultures usin
of CA1 (A) and CA2 (D) were split from standard cultures using MEF/S
(B, E) feeders in HEScGRO medium. Both hESC lines—CA1 and CA
fibroblast feeder XHEFa or XHEFb for 38 passages when passaging ev
fibroblasts XHFFA or XHFFB were lost within a few passages as indicat
medium and/or passage numbers are critical for xeno-free cultures o
original culture was lost (C, F, maintaining the total hESC passage nu
CA2 has been passaged from XHFFB to XHFFA at P7 (F). As a control
conditions using MEF/SR up to passage 30 (A, D).fibroblasts, leading to a 25% reduction of cells within 6 days
compared to medium with human serum (data not shown).
When the fibroblasts were plated at correspondingly higher
densities, hESC exhibit the classical multilayer colony
appearance (Figs. 3I, L) typical of MEF/SR cultures. During
the first 10 passages, the density of XHEF feeders was kept
identical to that of foreskin fibroblast cultures for better
experimental comparison. From passage P+11 onward,
however, the density of XHEF feeders was increased
(1.2×106 in a 6 well) leading to changed colony formation.
(Figs. 3I, L, 5A–D). Irrespective of the change in colony
appearance in sparse feeders, single cells showed a normal
morphology with a high nucleus to cytoplasm ratio and one to
three nucleoli. The transfer of CA1 and CA2 from MEF/SR to
xeno-free culture conditions using XHEF feeders, enzymatic
passaging, and ROCK inhibition could be repeated with the
same success.
In contrast to XHEF, hESC cultured on XHFF showed only
colony formation and undifferentiated growth during the
initial passage (P1). After the first passage under xeno-free
conditions, cultures were subject to differentiation, showed
reduced proliferative capacities, and had to be aborted.
Transfer of hESC fromMEF/SR to XHFF was performed several
times with different feeder densities, but at no time could
the hESC be maintained in an undifferentiated state. Similar
results were obtained when passaging hESC from XHEF
cultures to XHFF feeders at different time points (Fig. 2).
Only CA2 on XHFFB could be maintained until passage 10,
when cultures using XHFF were discontinued.
Proliferation rates were analyzed during the first 10
passages under xeno-free culture conditions (Fig. 4), dem-
onstrating that the growth of CA1 was more affected by the
fibroblast type compared to CA2. On XHEF, CA1 could be
maintained with good proliferation properties, with increas-
ing proliferation rates on fibroblasts XHEFa. On foreskin
fibroblasts on the other hand, only the first passage of a newg human foreskin or embryonic fibroblasts. Low passage numbers
R to xeno-free culture conditions (P1) using XHFF (C, F) or XHEF
2—could be continuously maintained on the human embryonic
ery 7 days. In contrast, hESC cultures using the human foreskin
ed by a double slash. To test that the fibroblasts, rather than the
f hESC, CA1 and CA2 were passaged from XHEF to XHFF when the
mber) leading to loss of cultures again within few passages. Also,
CA1 and CA2 were also maintained under their original culture
Figure 3 Morphology of hESC in xeno-free cultures. CA1 (A–C, G–I) and CA2 (D–F, J–L) grown on human foreskin fibroblast XHFFA
(A–C) and XHFFB (D–F) compared to embryonic fibroblasts XHEFa (G–I) and XHEFb (J–L). All fibroblasts support growth of CA1 and CA2
after initial passaging (P1) from MEF/SR to xeno-free culture conditions (A, D, G, J). After first passaging in xeno-free cultures, hESC
show poor growth on XHFF and are subject to differentiation (B, E). Also, when hESC were transferred from XHEF to XHFF cultures
differentiated within 2 passages (C). CA1 as well as CA2 cultured on XHEF show good proliferation capacities with confluent wells on
the day of passaging (H, K). Pictures were taken at Day 6 of each passage. Depending on the density of the fibroblasts, CA1 and CA2
cultured on XHEF exhibit a more monolayer-like (H, K) morphology (lower feeder density), or multilayer-like (I, L) colony morphology
(higher feeder density).
73Human embryonic fibroblastsculture showed comparable proliferation properties. During
the next passages proliferation was strongly reduced due to
differentiation of the cultures (Figs. 3B, C, E).
Marker gene expression and karyotype of hESC
FACS analysis for Oct4, Sox2, TRA-1-60, and SSEA-4 performed
on CA1 and CA2 after 38 passages under xeno-free conditions
revealed a high percentages of cells expressing these marker
genes when cultured on XHEFa and XHEFb (Fig. 5E). Homoge-
neous expression of Oct4 in the hESCcolonieswas confirmedby
immunostaining (Figs. 5F–M). The use of high passage (P25)
embryonic fibroblasts as feeders for these analyses clearly
shows that both XHEFa and XHEFb maintain supporting
properties for hESC after long-term culture.
Karyotype analysis was performed after 13 passages under
xeno-free conditions. A normal male karyotype (46, XY) was
verified for CA1 on XHEFa and XHEFb as well as for CA2 on
XHEFb (Figs. S2A, B, D). For CA2 on XHEFa, 65% of cellsrevealed a normal karyotype, while the remaining showed
trisomy of chromosome 12, a known recurrent aberration in
human ES cell cultures (Fig. S2C).
Differentiation capacities of hESC after long-term
culture under xeno-free conditions
To prove maintenance of hESC pluripotency after long-term
culture (35 passages) under xeno-free conditions using
human embryonic fibroblasts, we performed teratoma
assays. Tumors formed after 8 weeks of subcutaneous growth
in immune-deficient mice, and histological analysis revealed
formation of tissues of all three germ layers (Fig. 6) in
teratomas from both CA1 and CA2 on either XHEFa or XHEFb
feeders.
We also measured the expression of stem cell markers in
CA1 and CA2 after 20 passages in xeno-free culture on XHEF.
Marker gene expression, measured by quantitative PCR, was
compared to the same hESC cells cultured on MEF/SR
Figure 4 Proliferation rates of hESC cultured on human fibroblasts. Proliferation rates for CA1 (A, C) and CA2 (B, D) on human
foreskin fibroblasts (C, D) or human embryonic fibroblasts (A, B) were obtained for the first 10 passages after transfer from MEF/SR.
Cultures were performed in triplicates in 12-well plates and cell numbers counted at the time of passaging (Day 7). A control well with
feeders only was counted and subtracted form the number of cells in each well. Graphs show the average cell number of nonfeeder
cells with standard deviation of the mean. Arrows indicate the passage numbers over which cultures could be maintained. Individual
graphs in C and D represent the different approaches of hESC transfer to XHFF either from MEF/SR (P1) or from parallel XHEF cultures
(P4, P6, P9 in C; P4 in D) at the noted passages. hESC transferred from XHEF to XHFF exhibit the same loss of culture within 3 passages
as cultures started from MEF/SR, indicated by a double slash (see Fig. 2).
74 M. Kibschull et al.(Figs. 7A–C). hESC cultured on XHEF show higher or equal
transcript expression for Oct4 (Fig. 7A), Nanog (Fig. 7B), and
Sox2 (Fig. 7C), compared to corresponding cultures using
MEF/SR. Moreover, both hESC lines show a higher pluripo-
tency marker gene expression when cultured on fibroblasts
XHEFa compared to XHEFb.
To determine the differentiation capacities of hESC
cultured for 25 passages on XHEF under xeno-free conditions,
we performed an embryoid body (EB) formation assay. To
obtain better quantification of marker gene expression, we
used the Aggrewell400 method for generation aggregates of
uniform size (Figs. 7D–F). The EBs were cultured until Day 14
with medium changes every other day. Quantitative RT-PCR
analysis was performed for key pluripotency markers (Oct4,
Nanog, Sox2), and for lineage markers for ectoderm (Sox1
(Parmar and Li, 2007), Pax6 (Watanabe et al., 2005), β-3-
tubulin (Golebiewska et al., 2009)), endodermal (Sox17
(Seguin et al., 2008), Gata4 (Hyslop et al., 2005)), and
mesodermal (Flk1 (Woll et al., 2008), CD34 (Srivastava et al.,
2007), HBE1 (Ma et al., 2008), TNNC (Narita et al., 1997))
lineage markers. Expression of all of the tested markers can
be detected in undifferentiated hESC cultures (due to some
degree of spontaneous differentiation) but expression levels
are increased in embryoid bodies, indicating that they have
the capacity to differentiate into cells of all the three
embryonic lineages. Figs. 7G–L show the relative fold changeof these marker genes in EBs compared to undifferentiated
hESC for both hESC lines CA1 and CA2 cultured under
standard conditions with MEF/SR, or under xeno-free
conditions with XHEF feeders. Endo- and mesodermal
markers are strongly up-regulated during EB formation in
both CA1 and CA2 under xeno-free and MEF/SR culture
conditions. The neural marker genes Pax6, β-3-tubulin, and
Sox1 are already expressed in undifferentiated hESC cultures
(data not shown). Only Sox1 shows an up-regulation in EBs,
whereas Pax6 and β-3-tubulin expression remains unchanged
or reduced in EBs. An obvious difference under xeno-free
culture conditions was detected in the case of CA1. Whereas
the pluripotency markers Oct4, Nanog, and Sox2 are only
slightly changed in EBs formed form hESC cultures using MEF/
SR, EBs formed from xeno-free cultured hESC show a much
weaker expression of these marker genes (Figs. 7I, K). CA2 in
contrast shows a similar expression of the pluripotency
marker genes in EBs, independent of whether hESC have
been cultured under xeno-free conditions using XHEF feeders
or standard conditions using MEF/SR (Figs. 7H, J, L).Discussion
For future therapeutic applications of hESC, culture condi-
tions must be generated that are free of any xenogeneic
Figure 5 Morphology and marker gene expression of high passage hESC cultured on human embryonic fibroblasts. CA1 on XHEFa
(A) or XHEFb (B) as well as CA2 on XHEFa (C) or XHEFb (D) show normal morphology after 38 passages in xeno-free cultures when
cultured on embryonic fibroblasts at P25. (E) Flow cytometry analysis of hESC for Oct4 and Sox2 (P38) as well as TRA-1-60 and SSEA-4
(P39) show strong expression of marker genes for pluripotency at high passages. (C) Oct4 immuno-labeling (F–I) and corresponding
DAPI staining (at hESC passage P35) reveal homogeneous expression of Oct4. CA1 on XHEFa (F, J) or XHEFb (G, K) and CA2 on XHEFa (H,
L) or XHEFb (I, M). Scale bars, 100 μm in A–D, 50 μm in F–M.
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Figure 6 Histological analysis of hESC teratomas demonstrates pluripotency of hESC lines. After 35 passages of culture under xeno-
free conditions both CA1 and CA2 cultured on embryonic fibroblasts differentiate into tissues of mesodermal (A–H), ectodermal (I–P),
and endodermal (Q–T) germ layers. Teratoma showmuscle (A, B, D, arrowheads); b, bone (C); c, cartilage (E–H), pigmented cells (I, J,
arrows); n, ganglion-like neuroepithelium (K, L); s, squamous epithelium (M, O); neural tube-like epithelium (N, P, arrows);
respiratory-like epithelium (Q, R, S, arrows); and gut-like epithelium (S) with goblet cells (arrowheads). Scale bars, 100 μm.
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pathogens or substances that might induce an immune
reaction in recipients (Mallon et al., 2006). Several xeno-
free culture media with a serum-free formulation are
commercially available. However, a critical component in
hESC culture is the use of fibroblasts that thus far have been
either of animal (murine) origin or in the case of human
fibroblasts isolated from foreskin, placenta, and endometri-
um. These fibroblasts needed to be combined with xeno-
factors in the culture media in order to sustain a proper
pluripotent state of the hESCs (Amit et al., 2003; Richards et
al., 2003, 2002; Lee et al., 2005; Hovatta et al., 2003;
Genbacev et al., 2005).
In this study, we derived human embryonic fibroblasts
under xeno-free conditions. When these are used as feeders
they support growth and pluripotency of hESC. XHEF could be
easily isolated according to methods used for MEF, by
mincing and enzymatic digestion of tissue with xeno-free
TrypLE Select and culture in medium with human serum and
bFGF. XHEF show high viability after cryopreservation,
passaging, and mitomycin C arrest and were shown to befree of human pathogens and mycoplasms. We analyzed their
growth and ability to serve as feeder for hESC up to passage
25 without detecting senescence or diminished feeder
properties. This observation and the large number of stock
vials that could be generated from one fetus obviate the
need to generate new fibroblasts on a regular basis as is the
case for MEF. Therefore human embryonic fibroblasts reveal
the same practical properties known from foreskin fibro-
blasts, which are known to be expandable to high passages
while maintaining support for hESC in xeno-free culture
systems (Meng et al., 2008).
Using XHEF as feeders, we have established a completely
xeno-free culture system for hESC using the HEScGRO culture
medium, and human recombinant gelatin which allows
passaging of enzymatic dissociated single cells. The use of
the ROCK inhibitor Y-27632 further increased cell survival
when culturing hESC on human fibroblasts. It was recently
reported that CA1 can be cultured under xeno-free condi-
tions using HEScGRO and foreskin fibroblasts as feeders, but
that study used mechanical passaging of colonies (Meng et
al., 2008). Our attempts to transfer hESC from MEF/SR
Figure 7 Stem cell marker expression and differentiation capacities of hESC cultured under xeno-free conditions. qPCR analysis for
(A) Oct4, (B) Nanog, and (C) Sox2 in undifferentiated ES cells reveals higher levels of stem cell marker expression for hESCs cultured on
XHEF/HEScGRO compared to MEF/SR. hESC form embryoid bodies after N25 passages of culture under xeno-free conditions: (D) cystic
EBs of CA1 on XHEFa at Day 14. CA2 on XHEFb at Day 4 forming solid (E) and at Day 14 forming cystic EBs (F). (G–L) Quantitative RT-PCR
results of marker genes expressed in embryoid bodies after 14 days in suspension culture. After long-term culture under xeno-free
conditions, CA1 reveals a faster down-regulation of pluripotency marker genes during EB formation compared to CA1 grown with MEF/
SR. In contrast, CA2 exhibits a similar regulation of marker genes during EB formation independent of former culture conditions. Scale
bars, 200 μm.
77Human embryonic fibroblastscultures conditions to xeno-free media using these foreskin
fibroblasts were not successful, and the hESC differentiated
within a few passages. Single cell passaging using accutase orrecombinant enzymes has been described for hESC on MEF
(Bajpai et al., 2008) or foreskin fibroblasts (Ellerstrom et al.,
2007); however, these studies used media containing SR.
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which allows derivation and long-term culture of hESC on
human foreskin fibroblasts using a newly developed culture
medium (Rajala et al., 2010). They compared the perfor-
mance of their media formulation on the growth of hESC to
HEScGRO and found that HEScGRO was not able to maintain
undifferentiated growth of hESC when cultured on foreskin
fibroblasts. This strongly supports our finding that hESC
cultures on human foreskin fibroblasts under xeno-free
conditions are challenging. Whereas Rajala et al. (2010)
developed a new culture medium that allows growth of hESC
under xeno-free conditions, our own study uses embryonic
instead of foreskin fibroblasts to achieve a working xeno-free
culture system. In addition, Rajala et al. used mechanical
passaging in the first passages of xeno-free cultures, whereas
only enzymatic passaging can be used in xeno-free cultures
with human embryonic fibrobalsts (Rajala et al., 2010). This
clearly shows that beside the composition of the medium,
the source of fibroblasts to serve as feeders has a strong
influence on successful xeno-free hESC culture. The mechan-
isms responsible for the preference of hESC for embryonic
fibroblasts under xeno-free conditions are unclear. Fibro-
blast feeders serve as a substrate for hESC and they produce
factors that maintain pluripotency (Prowse et al., 2007). It
may be that both properties support attachment and survival
of hESC after enzymatic passaging. The source of fibroblasts
has been shown to play a role, with fetal fibroblasts showing
better performance in maintaining hESC cultures compared
to adult feeders (Richards et al., 2003). However, the
availability of human foreskin has led to this tissue being
chosen by most groups. We found that XHEF fibroblasts are
more sensitive to HEScGRO culture medium than feeders
derived from postnatal tissue in that HEScGRO slowed down
the proliferation rate of XHEF fibroblasts. Mitotically
inactivated XHEF feeders could be maintained in medium
with human serum for 10 days without changing morphology,
while the same cells in HEScGRO started detaching 5 days
after arrest. To achieve hESC growth as multilayer colonies,
25% more XHEF feeders had to be plated compared to
cultures using foreskin fibroblasts. Although colony forma-
tion was dependent on the density of feeders, pluripotency
of hESC was not affected. We also observed an increase in
the growth rate of hESC under xeno-free conditions in
accordance with previous reports (Meng et al., 2008;
Ellerstrom et al., 2007). The average splitting ratio during
the initial 10 passages of CA1 was 9.4 on XHEFa, 7.0 on
XHEFb, and for CA2 7.1 on XHEFa, 6.0 on XHEFa.
Our xeno-free culture conditions made single cell
passaging possible, and we could also generate EBs from
single cell suspensions. Although both hESC lines retained a
normal karyotype, we did observe an accumulation of a
chromosomal abnormality in one of our cultures. After 13
passages under xeno-free culture conditions 65% of the cells
were normal, whereas 35% showed a trisomy of chromosome
12, which is known as a recurrent aberration in hESC
associated with high proliferation rates (Draper et al.,
2004; Spits et al., 2008). This clone also showed a low
number of EBs formed which might be associated with the
changed karyotype. As the parallel cultures exhibited a
normal karoytype, this observation is probably a randomly
appearing phenotype, which is not associated with the
culture system itself. However, single cell passaging couldcontribute to promotion of chromosomal abnormalities,
especially when leading to high proliferation rates.
To our surprise, most of the hESC cultures on XHEF
revealed a stronger expression of the stem cell marker genes
Oct4, Nanog, and Sox2 compared to cultures on MEF/SR,
maybe due to the 10× higher numbers of feeders used in the
xeno-free culture system compared to standard cultures
with MEFs. hESC on XHEFa exhibited high expression levels of
the marker genes and splitting ratios indicated that XHEFa is
a better feeder than XHEFb. This might be due to individual
genetic differences of both embryonic fibroblasts and/or
their behavior in the used media or culture systems,
respectively. Further analysis of these cells will give insight
into potential fibroblast factors (i.e., secreted molecules,
matrix components) that are responsible for their advantage
in supporting growth of hESC compared to foreskin
fibroblasts.
It has been shown before that CA1 and CA2 are able to
form teratomas when injected into immune-deficient mice
(Adewumi et al., 2007). This capacity is maintained after
long-term culture under xeno-free culture conditions. In
addition, in the present study we quantified the change in
marker gene expression for ecto-, endo-, and mesodermal
lineages in embryoid bodies by qPCR, to detect differences in
differentiation capacities after long-term culture under
xeno-free conditions. Despite the random fluctuation of
spontaneous differentiation levels, lineage differentiation
was similar in EBs derived from xeno-free hESC cultures
compared to MEF/SR cultures. In particular, endo- and
mesodermal markers were found to be very consistently
expressed. The ectodermal markers were expressed similarly
in hESC and EBs. Only Sox1 was absent in hESC and induced in
EBs. We also formed neurospheres from single cell hESC in
serum-free medium and could detect a strong up-regulation
of Sox1 in both CA1 and CA2 with both XHEF sources proving
the capacity of the cells to form neural progenitors (data not
shown).
The only obvious difference in differentiation capacities
was that EBs formed from CA1 cultured under xeno-free
conditions showed very low expression of pluripotency
marker genes compared to the controls cultured in MEF/
SR. This affected only CA1 and not CA2, where pluripotency
markers remained expressed in EBs at a level comparable to
undifferentiated hESC. This was an interesting finding as
both hESC lines are genetically similar “nonidentical twins”
and were derived in parallel. A down-regulation of pluripo-
tency markers, however, is necessary for differentiation of
hESC into defined cell types. Thus, beside tests for
proliferation and undifferentiated growth of hESC, differen-
tiation capacities should be quantified more intensively to
find appropriate culture systems for future therapeutic
applications.
We attempted to culture CA1 and CA2 in a feeder-free
system using CELLstart from Invitrogen as a matrix and
XHEF-conditioned HEScGRO medium, but cultures showed
increasing levels of differentiation and poor proliferation
and could not be maintained for more than 3 passages (data
not shown). Recently, Meng et al. (2010) published a feeder-
free system using matrix isolated from human foreskin
fibroblasts and HEScGRO medium, where cells needed 10
passages of adaptation to the new conditions. This indicates
that a combination of culture media, matrixes, and
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culture systems.
Interestingly, CA1 and CA2 could be transferred to XHEF
feeders without an adaption phase of mechanical passaging
and differentiation was absent from these xeno-free cultures
from the first passage. The lack of an adaption phase makes
these fibroblasts valuable for derivation of hESC or under
xeno-free conditions. Recently, one of these embryonic
fibroblast cells (XHEFb) was used to derive iPS cells using
piggyBac transposition, a safe method to generate patient-
specific pluripotent stem cell lines (Woltjen et al., 2009; Kaji
et al., 2009). Our xeno-free culture systemwill also allow the
derivation of iPS cells under “safe” culture conditions, which
reduce the risk of transmitting pathogens.Material and methods
Generation of human embryonic fibroblasts
Tissues for isolation of fetal fibroblast were collected from
pregnancies undergoing elective social termination of
pregnancy at weeks 13 and 14 of gestation, respectively.
Ethics committee approval was obtained from Mount Sinai
Hospital Ethics Review Board and all donors gave written
informed consent.
Clusters of connective tissues were dissected from upper
limbs of the fetuses,washed in PBS (Invitrogen, Carlsbad, CA),
minced, and digested in 10 ml of TrypLE Select (Invitrogen) for
15 min at 37 °C in a shaking water bath. The suspension was
allowed to settle for 2 min, before the supernatant containing
the cells was collected and the pellet redigested with TrypLE.
The combined supernatants were mixed with 1 vol of xeno-
free human fibroblast (XHF) medium containing DMEM
(Invitrogen), 15% human serum (Wisent, Mississauga, Canada),
2 mMGlutaMAX (Invitrogen), 0.1 mM nonessential amino acids
(Invitrogen), 0.1 mM 2-mercaptoethanol (Invitrogen), 100 U/
ml penicillin, 0.1 mg/ml streptomycin (Invitrogen), and
10 ng/ml bFGF (FGF2; Peprotech, Rocky Hill, NJ). After
centrifugation at 200×g for 10 min the cells were suspended
in 20 ml of XHFmedium, plated (passage P0) into 10-cm dishes
(BD Biosciences, Mississauga, Canada), and incubated to
confluence at 37 °C, 5% CO2 with medium changes every
2 days. The confluent monolayer was dissociated with TrypLE
for 7 min at 37 °C and after centrifugation resuspended cells
were split 1:5. Stock vials of both xeno-free-derived human
embryonic fibroblast sources (named XHEFa and XHEFb) were
frozen at P3 containing 3×106 cells in 90% human serum and
10% (v/v) DMSO (Sigma, Oakville, Canada). Cryovials were
incubated at -80 °C for 24 h and then transferred to long-term
storage into liquid nitrogen.
Two independent lines of xeno-free-derived human
foreskin fibroblasts were kindly provided by Dr. D.E.
Rancourt (University of Calgary). The lines—in this study
named XHFFA and XHFFB—were expanded in XHF medium
and stock vials were frozen at P5 and P7, respectively.
The four human fibroblast were screened for the absence
of potential human pathogens by RADIL (Research Animal
Diagnostic Laboratory, Columbia, MO) using a PCR-based
assay (h-IMPACT profile). Sample preparation was performed
according to the company's standard operating procedures.
All human fibroblasts were found negative for the testedpathogens (Human immunodeficiency virus 1 (HIV1), Human
immunodeficiency virus 2 (HIV2), Hepatitis A virus, Hepatitis
B virus, Hepatitis C virus, Sin Nombre virus, Hantaan virus,
and Seoul virus and Mycoplasma spp.).
Preparation of human fibroblast feeders
Confluent fibroblast layers were incubated with 10 µg/ml
mitomycin C (Sigma) in growth medium for 2 h. The medium
was removed and the cells washed three times with PBS,
dissociated with TrypLE, centrifuged at 200×g, resuspended,
and plated at appropriate densities. Feeders from human
embryonic and foreskin fibroblasts were plated in XHF
medium on tissue culture plastic ware that had previously
been gelatinized with 0.1% human recombinant gelatin
(FibroGen, San Francisco, CA) in H2O to achieve xeno-free
conditions. Feeders from mouse embryonic fibroblasts (MEF)
were plated on plasticware gelatinized with EmbryoMax 0.1%
gelatin (Millipore, Bedford, MA) in MEF medium containing
DMEM, 15% FBS (Hyclone, Logan, UT), 2 mM GlutaMAX,
0.1 mM nonessential amino acids, 0.1 mM 2-mercaptoetha-
nol, 100 U/ml penicillin, and 0.1 mg/ml streptomycin.
hESC cultures
CA1 and CA2 were originally derived and cultured on a MEF
feeder layer, in medium containing KO-DMEM (Invitrogen),
20% KOSR (Invitrogen), 2 mM GlutaMAX, 0.1 mM nonessential
amino acids, 0.1 mM 2-mercaptoethanol, 100 U/ml penicil-
lin, 0.1 mg/ml streptomycin, and 10 ng/ml bFGF. Cultures
were dissociated using TrypLE Select for 3 min at room
temperature (RT), centrifuged at 150×g for 4 min, and split
at a ratio of 8–12 (~2×105 cells/6 well).
To apply xeno-free culture conditions to hESC, early
passages of CA1 (P6) and CA2 (P9) were initially transferred
to xeno-free human feeder layers in SR medium. After 24 h
the culture medium was changed to HEScGRO (Millipore), a
xeno-free complete culture medium, which contains 20 ng/
ml bFGF. HEScGRO was supplemented with 100 U/ml
penicillin; 0.1 mg/ml streptomycin and the medium was
changed every other day. Before splitting xeno-free hESC
cultures, the ROCK (Rho-associated kinase) inhibitor Y-27632
(EMD Chemicals, Gibbstown, NJ) was added at a concentra-
tion of 10 μM to the culture medium for 1 h. Cells were then
dissociated using TrypLE for 3 min at RT, diluted in XHF
medium, centrifuged for 4 min at 150×g, and resuspended in
HEScGRO. The total cell number of the suspension was
counted and hESC numbers were corrected by counting a
culture well with feeders only. Cells were split at appropri-
ated dilutions in HEScGRO containing 10 μM ROCK inhibitor,
and the medium was changed after 24 h to HEScGRO only.
Stocks of xeno-free hESC were frozen in 90% human serum,
10% DMSO, and stored in liquid nitrogen.
Proliferation assay
hESC (2×105) were plated in triplicate into 12-well plates
with 3×105 preplated human feeders. At Day 7, cultures were
washed with PBS and cells were dissociated with TrypLE. The
total cell number of dissociated cells was analyzed using the
CASY TT cell counter (Innovatis, Hannover, Germany). To
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containing feeders only was cultured and counted in parallel.
The dissociated cells from the 3 triplicates were then
combined, centrifuged, and suspended in HEScGRO. Cell
numbers were counted again and 2×105 hESC were plated.
Genotyping
Genomic DNA was isolated from fibroblasts using proteinase
K lysis of cells followed by alcohol precipitation (Kibschull et
al., 2004). Sex determination by PCR was performed
according to Akane et al. (1992) using specific primers
directed to the amelogenin locus resulting in an X-specific
863-bp and a Y-specific 674-bp amplicon.
Karyotyping
Karyotype analysis was carried out after culturing CA1 and
CA2 for 12 passages under xeno-free culture conditions on
human embryonic fibroblasts XHEFa or XHEFb, respectively.
Cultures were submitted to Cell Line Genetics (Madison, WI)
and cytogenetic analysis was performed on 20 G-banded
metaphase cells.
Flow cytometry and immunostaining for Oct4
For flow cytometry 106 hESC were fixed and permeabilized
using the Intraprep Permeabilization Kit (Beckman Coulter,
Mississauga, Canada), and sequentially probed with a
directly fluorescent-label-conjugated Oct4, Sox2, Tra-1-60,
or SSEA-4 antibody (all Millipore, Mississauga, ON) Samples
were assayed on a FACSAria flow cytometer (BD Biosciences).
For Oct4 immunostaining, cells were fixed with 4% PFA for
10 min at RT and then permeabilized with 0.1% NP-40 in PBS
for 30 min at RT. After 3×10 min washes in PBS/0.1%
Tween20 (Sigma) and blocking in 5% FBS in PBS for 1 h, a
primary Oct4 antibody (Millipore) was applied overnight at
4 °C. After 3×10 min washes in PBS/0.1% Tween20 cells were
mounted with Vectashield+DAPI (Vector Laboratories, Bur-
lingame, CA) and photographed.
Teratoma assay—Analysis of pluripotency in vivo
Animal experiments were performed at the Toronto Centre
for Phenogenomics, Canada, with ethical approval according
to Canadian laws. Confluent cultures of hESC were dissoci-
ated using TrypleE select and cell numbers counted. Cells
(5×106) were centrifuged and resuspended in 150 μl of a 1:1
solution of high concentration Matrigel (BD Biosciences) in
DMEM. Cell aliquots (5×106) in Matrigel/DMEM were injected
subcutaneously into both flanks of immunodeficient BALB/c
mice at 8 weeks of age. At 7–8 weeks after injection tumors
were dissected and processed using routine paraffin embed-
ding, sectioning, and H&E staining.
Embryoid body formation
Formation of embryoid bodies was carried out using
AggreWell400 plates (Stemcell Technologies, Vancouver,
Canada) as described by Ungrin et al. (2008). Briefly,AggreWell400 plates were coated with 5% (w/v) Pluronic F-
127 (Sigma) in PBS for 30 min at RT immediately before use.
A single cell suspension of 2.4×106 undifferentiated hESC in
MEF medium with 10 mM ROCK inhibitor was applied to the
AggreWell400 plate. The plate was then centrifuged for
5 min at 200×g, to equally distribute the cells in the
microwells, and incubated at 37 °C, 5% CO2. Embryoid bodies
were the transferred to ultralow adherence 6-well plates
(Corning, Corning, NY) with MEF medium and collected at
Day 14 after aggregation.
Reverse transcription and quantitative PCR
Total RNA from hESC and embryoid bodies was isolated using
the RNeasy Mini kit (Qiagen, Mississauga, Canada). All
procedures were performed according to the manufacturer's
protocols and included an on-column DNase I digestion step.
One microgram of RNA was reverse-transcribed to cDNA using
the TaqMan Reverse Transcription Reagents (ABI, Foster City,
CA) in a thermal cycler with 10 min at 25 °C, RT for 30 min at
42 °C, followed by enzyme inactivation for 5 min at 95 °C.
Quantitative PCRs were performed in triplicates on an
Eppendorf (Mississauga, Canada) realplex2-S mastercycler
using 10 ng of cDNA, 70 nM of each primer, and 10 μl iTaq
SYBR Green Supermix (Bio-Rad, Mississauga, Canada) in a 20 μl
PCR reaction. The absence of DNA contamination from RNA
samples was proven by running control reactions without
reverse transcriptase. The relative expression ofmarker genes
was determined using the delta-delta Ct method with β-actin
as a housekeeping gene and Pfaffl modification (Pfaffl, 2001).
All primers were titrated for efficiency, and specificity of the
amplicon was assured by melting curve analysis. The following
primers were generated using Primer-Express 2.0 software
(ABI): Oct4/for, 5′-GAACATGTGTAAGCTGCGGC-3′; Oct4/rev,
5′-TGGTTCGCTTTCTCTTTCGG-3′; Nanog/for, 5′-TACCT-
CAGCCTCCAGCAGAT-3′; Nanog/rev, 5′-TGCGTCACACCATTGC-
TATT-3′; Sox1/for, 5′-CTTAGGTTTCCCCTCGCTTTC-3′; Sox1/
rev, 5′-TGCAGGCTGAATTCGGTTCT-3′; Pax6/for, 5′- TCTAA-
TCGAAGGGCCAAATG-3′; Pax6/rev, 5′-TGTGAGGGC-
TGTGTCTGTTC-3′. Primer sequences for β-3-tubulin, Sox17,
Gata4, Flk-1, CD34, HBE1, and TNNC were obtained from
Ungrin et al. (Ungrin et al., 2008).
Supplementary materials related to this article can be
found online at doi:10.1016/j.scr.2010.08.002.Acknowledgments
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